Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ras peptide cancer vaccine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-8 of 8 for your search:
Start Over
Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: NCI
Protocol IDs: CDR0000066874, NCI-99-C-0023L, NCI-T98-0034, T98-0034, NCT00019591
Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000064192, NCI-95-C-0105A, NCI-T94-0096N, T94-0096, NCT00019084
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000065656, NCI-97-C-0141F, NCI-T96-0078, T96-0078, NCT00019331
Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: CDR0000063475, NCI-94-C-0096D, NCI-T93-0152N, T93-0152, NCT00019006
Phase IB Study of Vaccination with a Recombinant Mutant ras Protein with the Immunologic Adjuvant QS21 in Patients with Adenocarcinomas Expressing an Activated ras Oncoprotein (Summary Last Modified 03/98)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-97-C-0018, CRB-9411, NCI-NMOB-9608, NCI-T95-0048N, T95-0048
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 17
Sponsor: NCI, Other
Protocol IDs: 98-037, MSKCC-98037, NCI-G99-1542, NCT00003959
Vaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal Cancer
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: FCCC-98026, NCI-T97-0051, T97-0051, NCT00006387
Start Over